INK4a and p27
Introduction
For more than 20 years, human adenoviruses have been a powerful tool for studying cellular processes such as the regulation of gene expression, alternative splicing, polyadenylation, replication and cell cycle progression. In particular, the analysis of the viral proteins encoded by early region 1A (E1A), has provided many insights concerning the ability of adenoviruses to regulate not only their own genes, but also those of their hosts, which are generally quiescent cells. In order for the virus to achieve maximal replication, it must induce S phase entry, and E1A alone can achieve this. E1A is also capable of inducing immortalization or transformation of primary cells, the latter in co-operation with other oncogenes like ras or E1B .
The E1A region of human Adenovirus 5 produces two major mRNAs, 12S and 13S, which encode nuclear proteins of 243 and 289 amino acids, respectively. These proteins dier only by an internal stretch of 46 residues unique to 13S. Comparison of E1A sequences from dierent adenoviral serotypes identi®ed three conserved regions: CR1 (residues 40 ± 80), CR2 (120 ± 139) and CR3 (140 ± 188 of Ade 5 289R) (reviewed in Bayley and Mymryk, 1994; Flint and Shenk, 1997 ; see Figure 1 ). In Ade 2 and Ade 5, CR3 is practically identical to the 13S-speci®c region and constitutes a potent transcriptional activation domain . This domain is dispensable for cell cycle entry and cellular transformation, since 12S is active in this regard .
The breakthrough in understanding E1A function came with the identi®cation of the Retinoblastoma gene product (pRb) as an E1A-interacting protein (Whyte et al., 1988) . That was the ®rst link to be established between E1A and the product of a tumor suppressor gene, and helped elucidating key molecular mechanisms controlling cell proliferation. pRb and the related proteins p107 and p130 (collectively called`pocket proteins') negatively regulate growth through association with various cellular targets, and in particular with transcription factors of the E2F/DP family. Pocket proteins repress E2F-target genes, which include regulators of S phase entry (e.g. B-myb, cyclin E, p107) and genes required for DNA replication (e.g. DHFR, MCMs, ORCs, DNA pola) (DeGregori et al., 1997; Leone et al., 1998; Ohtani et al., 1996; Yan et al., 1998 ; for reviews, see Helin, 1998; Weinberg, 1995) . E1A binds pRb, p107 and p130 and displaces E2F from the pocket proteins. This results in release of E2F, activation of E2F target genes and progression through the cell cycle (reviewed in Bayley and Flint and Shenk, 1997) . In agreement with this, deletion or mutation of the sequences of E1A required for pRb-binding (CR2 and the N-terminal part of CR1) abolishes S phase entry and transformation by E1A Flint and Shenk, 1997) . Distinct E1A sequences, located at the extreme N-terminus and in the C-terminal part of CR1, are required for interaction with the p300/CBP family of histone acetyl-transferases (HATs) and for the biological activities of E1A Eckner, 1996; Shikama et al., 1997) . Even though the exact role of p300/CBP-binding in E1A transformation is not fully understood, it seems that E1A can regulate the activity of p300/CBP complexes in both a positive and a negative manner: (i) by preventing p300-mediated acetylation and activation of the tumor suppressor p53 (Chakravarti et al., 1999; Hamamori et al., 1999) ; and (ii) by directly inducing the HAT-activity of CBP (Ait-Si-Ali et al., 1998).
In normal cells, pRb-family proteins are inactivated by phosphorylation, catalyzed by cyclin-dependent kinase (CDK) complexes, including CDK4 or CDK6 (associated with D-type cyclins) and CDK2 (associated with cyclins E or A) (reviewed in Mittnacht, 1998; Sherr, 1994 Sherr, , 1995 Weinberg, 1995) . The activities of CDKs are regulated at many levels, and in particular by their interaction with two families of inhibitory proteins (CKIs) (Morgan, 1995; Sherr and Roberts, 1995) . The Cip/Kip family of CKIs includes p21 Cip1 , p27
Kip1 and p57 Kip2 , which bind to all G1-cyclin/CDK complexes. The second family includes the INK4  proteins p16   INK4a   , p15   INK4b   , p18  INK4c and p19   INK4d , which bind to CDK4 and CDK6. Ectopic expression of both classes of CKIs causes activation of pRb-family proteins, sequestration of E2F and subsequent cell cycle arrest in G1 (Alevizopoulos et al., 1997 (Alevizopoulos et al., , 1998 Guan et al., 1994; Hirai et al., 1995; Polyak et al., 1994; Quelle et al., 1995; Toyoshima and Hunter, 1994; Vlach et al., 1996) .
Several studies suggest that the major role of cyclin D/ CDK4 complexes is to inactivate pRb. For example, pRb-negative cells become insensitive to expression of p16 or microinjection of antibodies neutralizing cyclin D/CDK4 (Koh et al., 1995; Lukas et al., 1994 Lukas et al., , 1995a Medema et al., 1995) and ectopic expression of E2F-1 prevents G1 arrest by p16 (Alevizopoulos et al., 1997; DeGregori et al., 1995; Lukas et al., 1996; Mann and Jones, 1996) . However, E2F is not sucient to prevent growth inhibition by p27, implying that cyclin E/CDK2 complexes have an additional role(s) at the G1-S transition, distinct from pRb phosphorylation (Alevizopoulos et al., 1997; Mann and Jones, 1996) . Similar conclusions were reached by other groups (Chew et al., 1998; Hofmann and Livingston, 1996; Knudsen et al., 1998; Leng et al., 1997; Lukas et al., 1997; Ohtsubo et al., 1995; Resnitzky and Reed, 1995) . In summary, the ability of the CDK4 inhibitor p16 to arrest the cell cycle in G1 seems to depend essentially on activation of pRb and sequestration of E2F, whereas p27 not only activates pRb, but also impinges on other CDK2-regulated events (discussed in Dyson, 1998) .
We recently showed that expression of E1A in Rat1 ®broblasts, prevents cell cycle arrest by either p16 or p27 (Alevizopoulos et al., 1998) . Consistent with the notion that p16 functions via pRb, mutations in CR1 or CR2 that abrogate pRb-binding impair the ability of E1A to prevent p16-induced arrest. In order to prevent p27-induced arrest, E1A requires not only these pRb-binding domains, but also a distinct region spanning amino acids 26 ± 35. Binding to p300/CBP is dispensable for overcoming cell cycle arrest by either CKI (Alevizopoulos et al., 1998) . In summary E1A overrides normal regulatory constraints at the G1/S transition by acting at at least three levels: (i) by inactivating pRb-family proteins and releasing active E2F; (ii) by modulating the function of p300/CBP HAT complexes; and (iii) by targeting additional cellular proteins, which are presumably downstream targets of CDK2 in normal cell cycle control.
In this paper, we have analysed further the ability of E1A to overcome G1 arrest by CKIs. Alignment of E1A proteins from dierent serotypes revealed two conserved motifs, GFP and SDDEDEE, located within CR2. Mutation of these motifs impairs the ability of E1A to overcome G1 arrest by p16 and p27 but, surprisingly, does not prevent binding to pRb. In addition, we show that mutation of the CtBP-binding site in the C-terminus of E1A or removal of the last 52 amino acids have no eect on this activity of E1A.
Results

Construction and expression of novel E1A mutants
We recently showed that expression of Ade 5 E1A prevents either p16-or p27-induced arrest in Rat1 ®broblasts. Binding to pRb-family proteins but not to p300/CBP was required for this eect. In addition, residues 26 ± 35 of E1A were speci®cally required for overcoming p27-, but not p16-induced arrest (Alevizopoulos et al., 1998) . During the course of these studies we constructed several other E1A mutants, based on the identi®cation of additional conserved motifs (Figure 1 ). 12S E1A proteins from ®ve dierent serotypes share two major regions of conservation: CR1 (residues 40 ± 80) and CR2 (120 ± 139), implicated mainly in binding to pocket proteins and p300/CBP (reviewed in Bayley and . Closer examination of CR2 revealed that in addition to the pRb-interaction motif LXCXE, it contains two other conserved motifs: (i) GFP (128 ± 130 of Ade 5); and (ii) SDDEDEE (132 ± 138 of Ade 5). To assess the contribution of these motifs to the function of E1A, we constructed two Alanine-substitution mutants of Ade 5 E1A: GFP to AAA (mutant GFP-A3) and DDEDEE to AAAAAA (mutant DDE-A6, Figure 1a ). In addition, we mutated another conserved motif in the C-terminus of E1A (LDLS; mutant LDL-A4, Figure  1a ). This motif binds the cellular phosphoprotein CtBP (Schaeper et al., 1995 (Schaeper et al., , 1998 . Finally, we constructed a deletion mutant that lacks the last 52 amino acids of E1A (mutant DC52). This deletion removes not only the CtBP-binding site, but also several other clusters of conserved residues ( Figure 1a ).
Recombinant retroviruses encoding wild type or mutant E1A proteins together with drug-resistance markers were used to infect Rat1 cells. After selection, pools of infected cells were expanded and cell lysates were analysed by immunoblot with an E1A-speci®c antibody ( Figure 2 ). All E1A proteins were expressed at similar levels, with the exception of DC52, which accumulated at slightly lower levels ( Figure 2 ). In addition, cell lines expressing the various E1A proteins exhibited morphological alterations, grew faster, reached higher densities than vector-infected cells, and detached rapidly from the plates upon serum withdrawal (data not shown), as expected since E1A induces apoptosis in low serum .
GFP and SDDEDEE motifs are required for overcoming p16-and p27-induced arrest
To test whether the new E1A mutants prevent growth arrest by p16 or p27, we infected control Rat1 or E1A-expressing cells with retroviruses encoding either p16 or p27 together with a puromycin-resistance marker. In agreement with previous data, expression of p16 or p27 prevented colony outgrowth and induced accumulation of cells in G1, with concomitant depletion of S phase cells. E1A-expressing cells entered S phase and formed colonies with similar eciencies in the presence or absence of either CKI (Figure 3 and data not shown) (Alevizopoulos et al., 1998) . Mutants LDL-A4 and DC52 behaved like 12S E1A in these assays. In contrast, cells expressing GFP-A3 and DDE-A6 were arrested by p16 or p27 (Figure 3 and data not shown). Thus, the last 52 amino acids of E1A, and in particular the CtBP-binding site, are dispensable for preventing CKI-induced arrest, while the GFP and SDDEDEE motifs in CR2 are required.
E1A mutants GFP-A3 and DDE-A6 interact normally with pocket proteins
The observation that mutations in the CR2 motifs GFP and SDDEDEE impair the ability of E1A to overcome p16-and p27-induced arrest suggested that they might disrupt binding to pRb-family proteins, like mutations in the adjacent LXCXE motif (see Figure 1 ) (Alevizopoulos et al., 1998; Bayley and Mymryk, 1994) . To address this possibility, we immunoprecipitated wild type E1A, GFP-A3 and DDE-A6 from cell lysates and analysed immunoprecipitates by immunoblot for associated pocket proteins. Strikingly, all E1A proteins immunoprecipitated similar levels of pRb, p107 and p130 ( Figure 4a , arrowheads for pRb; see legend). This interaction was speci®c, since no pocket proteins were precipitated by the E1A antibody from control Rat1 cells. All cells expressed similar amounts of p107, while cells with wild type E1A consistently contained more pRb and p130 than control Rat1 cells or cells expressing GFP-A3 or DDE-A6 (Figure 4b ). While these dierences in total levels remain unexplained at the moment, they do not impinge on the conclusions from the association experiments. As an additional control, we measured the amount of E1A-associated CDK2. E1A binds CDK2 indirectly, via p107 and p130 and their interactions with cyclins E and A (reviewed in Bayley and Mymryk, 1994) . In agreement with the analysis of pocket proteins, all E1A variants immunoprecipitated similar levels of CDK2 (Figure 4a) . We conclude that mutants GFP-A3 and DDE-A6 interact with pRb-family proteins as eciently as wild type E1A.
Mutants GFP-A3 and DDE-A6 can relieve pRb-mediated repression of E2F transcription pRb is a potent inhibitor of E2F transcriptional activity in vivo. However, when bound to E1A, pRb is no longer able to bind E2F, which is therefore free to activate its target genes (for reviews see Dyson, 1998; Nevins, 1992) . To address whether the mutants GFP-A3 and DDE-A6 are capable of relieving pRb-mediated repression, we transiently transfected 293T cells with an E2F-responsive cyclin E promoter-luciferase reporter gene ( Figure 5 ). Consistent with previous data (Alevizopoulos et al., 1998; Geng et al., 1996; Ohtani et al., 1995) , overexpression of E2F-1 and DP-1 strongly transactivated this reporter. Activation was suppressed by co-expression of pRb ( Figure 5 ), but not of a pRb mutant defective in binding to E2F (Dex22) (Alevizopoulos et al., 1998; Qin et al., 1992) . Co-expression of wild type E1A (12S) counteracted pRb-mediated repression. As expected, the E1A mutant 124,135A (mutated in the LXCXE motif) was ineective. In contrast, mutants GFP-A3 and DDE-A6 were as active as 12S E1A in this assay ( Figure 5 ). All E1A proteins were expressed at comparable levels and none of them aected the basal activity of the reporter (data not shown). Similar results were obtained in COS7 cells. In conclusion, mutants GFP-A3 and DDE-A6 are fully able to bind pRb and derepress E2F in vivo, although they are incapable of preventing p16-and p27-induced arrest.
Effects of GFP-A3 and DDE-A6 on endogenous E2F activity
The above observations suggested that GFP-A3 and DDE-A6 were functional in sequestering Rb-family proteins and preventing repression of ectopically expressed E2F in virally transformed cell lines. To evaluate the ability of these mutants to stimulate the activity of endogenous E2F, we co-transfected wild type E1A and mutants in Rat1 cells together with a construct containing the Adenoviral E2 (and E3) promoter driving expression of Luciferase. Activation of the E2 promoter is mediated by two E2F binding sites (reviewed in Bayley and Nevins, 1992) and depends on the ability of E1A to liberate endogenous E2F from pocket proteins. Thus, this assay provides a direct measurement of E2F activity in the presence of various E1A mutants. In agreement with previous observations, wild type E1A, but not the pRb-binding mutant 124A,135A (Alevizopoulos et al., 1998) , was able to disrupt endogenous pocket proteins/ Figure 4 E1A mutants GFP-A3 and DDE-A6 interact eciently with pRb-family proteins. (a) E1A proteins were immunoprecipitated (IP) from the indicated cells (top) followed by immunoblotting (blot) for the indicated proteins. (b) Direct immunoblot analysis of the corresponding whole cell lysates. It is important to note here that the electrophoretic gels used in this experiment (10% polyacrylamide) do not resolve the hypo-and hyperphosphorylated forms of pocket protein. Thus, both forms of pRb co-migrate as the bands indicated by the arrowheads. The faster migrating pRb forms detected in the E1A-cell lysate (marked by asterisks) may represent degradation products or further dephosphorylated forms (Chen et al., 1989) . These additional pRb bands are not detected in a reproducible fashion, either alone or in association with E1A (Alevizopoulos et al., 1998 ; data not shown) Figure 5 The E1A mutants GFP-A3 and DDE-A6 are functional in relieving pRb-mediated repression of E2F transcriptional activity. 293T cells were transfected with an E2F-responsive cyclin E promoter-luciferase reporter gene together with plasmids encoding E2F-1, DP-1, pRb or E1A proteins (12S or mutants), as indicated. Relative luciferase units are expressed in fold-activation relative to the reporter alone. The data shown are from one of four independent experiments, which yielded the same results New function of E1A conserved region 2 K Alevizopoulos et al E2F complexes and to stimulate E2F activity 2.5-fold ( Figure 6 ). Most importantly, mutants GFP-A3 and DDE-A6 were as active as wild type E1A in this assay. These results, consistent with the co-precipitation and Rb-overexpression data (Figures 4 and 5) , indicated that GFP-A3 and DDE-A6 were indeed capable of activating E2F.
The above experiments addressed the activity of endogenous E2F on a transfected reporter gene. To further monitor expression of endogenous E2F-target genes in their natural chromatin context, we measured mRNA levels by Northern-blot analysis. We tested the MCM5, MCM7 and cyclin A genes, which all respond to E2F (Helin, 1998; Leone et al., 1998; Yan et al., 1998) . Expression of MCM5 and MCM7, and to a lesser extent of cyclin A, was suppressed in p16-and p27-arrested cells (Figure 7a ). Wild type E1A counteracted this eect, allowing sustained expression of E2F-target genes. As expected, the pRb-interaction mutant 124A,135A was inactive in this assay. Surprisingly, mutants GFP-A3 and DDE-A6 exhibited dierent properties: GFP-A3 restored expression of the tested genes in the presence of p16 and p27, whereas DDE-A6 was unable to do so. Thus, even though it can bind pocket proteins and derepress E2F in transient transfection assays (Figures 4 ± 6 ), mutant DDE-A6 fails to activate expression of endogenous E2F genes. Similar results were obtained when the protein levels of another E2F target gene, MCM3 (for which mRNA was not detectable), were measured by Western blot analysis (Figure 7b ). In contrast to the above genes, DDE-A6 restored expression of MCM4 (at least at the protein level), even though with a lower eciency than GFP-A3. Finally, neither GFP-A3 nor DDE-A6 restored expression of the cdc2 protein in the presence of p16 (Figure 7b) . Altogether, these data suggest that the two E1A mutants dierentially in¯uence the activity of speci®c E2F target genes in the presence of p16 or p27 (see Discussion).
Discussion
Adenovirus E1A is a potent oncogenic protein capable of interfering with normal regulatory processes upon its introduction in mammalian cells. One of the major biological consequences of E1A expression is the inactivation of pRb-family proteins and the subsequent release of active E2F (reviewed in Bayley and Nevins, 1992) . Consistent with this notion, mutants of E1A that fail to interact with pRb, and therefore do not release E2F, are defective in transformation (Dyson et al., 1992; Egan et al., 1989; Jelsma et al., 1989; Svensson et al., 1991; reviewed in Bayley and Mymryk, 1994) or in their ability to prevent G1-arrest by the CDK4/6 inhibitor p16 (Alevizopoulos et al., 1998) . Preventing arrest by the CDK2 inhibitor p27 requires not only the pRb-binding sequences of E1A, but also an additional region spanning amino acids 26 ± 35 (Alevizopoulos et al., 1998) . These residues are critical for interaction with a large cellular protein, p400, which remains to be characterized (Barbeau et al., 1994; Howe and Bayley, 1992) . Surprisingly, binding of E1A to p300/CBP is dispensable for overcoming arrest by either p16 or p27, even though it is crucial for the transforming activity of E1A (Alevizopoulos et al., 1998; Bayley and Mymryk, 1994) . In summary, the common determinant of E1A that imparts cellular resistance to p16 and p27 is its association with pocket proteins and the ensuing liberation of E2F. In this study we have analysed the role of additional residues within E1A. To evaluate the contribution of the E1A carboxylterminus, we constructed two mutants containing: (i) a deletion removing the last 52 amino acids of E1A (DC52); and (ii) alanine substitutions in the C-terminal CtBP-interaction motif (LDL-A4) (Schaeper et al., 1995 (Schaeper et al., , 1998 . The biological function of CtBP is not yet clear, but data derived from studies in Drosophila suggest that it is a co-factor of transcriptional repressors like Hairy, Snail, Knirps, KruÈ ppel and Enhancer of split (Nibu et al., 1998a,b; Poortinga et al., 1998) . Deletion mutants of E1A lacking the CtBPinteraction domain have enhanced tumorigenic potential suggesting that CtBP may be a negative regulator of E1A (Boyd et al., 1993) . Mutants LDL-A4 and DC52 were functional in bypassing p16-and p27-induced arrest, showing that CtBP binding is not required.
By aligning E1A from ®ve dierent Adenovirus serotypes we identi®ed two new motifs within CR2, GFP and SDDEDEE (Figure 1) , which are required for E1A to overcome G1 arrest by p16 and p27. Even though these residues lie next to the LXCXE motif required for pRb-binding, mutants GFP-A3 and DDEDEE-A6 were fully capable of interacting with pRb-family proteins. In transient transfection assays, these mutants were competent in relieving pRbmediated repression of an E2F-responsive reporter gene. Our data on Ade 5 E1A are consistent with a recent report describing a mutant of Ade 12 E1A (mutant CS-1) that bears a 69 bp deletion spanning the GFP and SDDEDEE motifs. CS-1 has lost transforming activity, despite the fact that it binds pocket proteins (and p300) and transactivates E2F target genes in transient transfections (PuÈ tzer et al., 1997) . It was also shown that Ser 132 in the SDDEDEE motif of Ade 5 E1A is phosphorylated in vivo, and is a target of casein kinase II in vitro (Whalen et al., 1996) . Mutation of this residue marginally reduced interaction with pRb in cells and had no signi®cant eect on the transforming activity of 12S E1A. Added to the loss of six acidic residues (DDEDEE), our DDE-A6 mutation may aect phosphorylation of Ser 132. It remains to be addressed whether Ser 132 phosphorylation plays any role in overcoming CKI-induced arrest. Altogether, the available data imply that the CR2 motifs GFP and (S)DDEDEE are critical for the biological function of E1A.
At face value, the transient transfection data in this work and in PuÈ tzer et al. (1997) would suggest that the GFP and SDDEDEE motifs of E1A act independently of E2F activation altogether. This would imply that p16-induced arrest requires events distinct from pRb-E2F control, which remain to be elucidated. However, we deem this explanation unlikely, since monitoring of mRNA levels for endogenous E2F targets genes yielded a picture distinct from transient transfection assays. Whereas mutant GFP-A3 restored expression of the MCM5, MCM7 and cyclin A mRNAs in the presence of p16 or p27, mutant DDE-A6 failed to do so. This result implies that the SDDEDEE motif of E1A is required for derepression of endogenous E2F target genes in cells expressing p16 or p27. Alternatively, mutant DDE-A6 may be able to induce expression of some target genes, not included among the mRNAs tested here (as suggested by analysis of MCM4 protein levels). Similarly, GFP-A3 may selectively activate some E2F-target genes, but not others (as suggested by its failure to restore expression of the cdc2 protein in the presence of p16). Although an exhaustive analysis of the expression levels of E2F target genes will be required, our data point to a function of the DDEDEE, and possibly also of the GFP motif in derepressing the transcription of E2F-target genes in their natural chromatin context.
Two potential scenarios could be involved in order to explain the defect of the GFP-A3 and DDE-A6 mutants. In the ®rst scenario, E2F or pRb/E2F complexes would recruit an additional repressor(s) (`X') that contributes to the silencing of E2F following expression of p16 or p27. Wild type E1A, but not GFP-A3 or DDE-A6, would be capable of sequestering X', therefore preventing inhibition of E2F and subsequent G1 arrest. A potential candidate for`X' could be HDAC-1, a histone deacetylase recently shown to co-operate with pRb in repressing E2F activity (Brehm et al., 1998; Ferreira et al., 1998; Luo et al., 1998; . Interestingly, the carboxy-terminal Zinc ®nger of HPV16 E7 binds HDAC-1 via a protein called Mi2, independently of pRb (Brehm et al., 1999) . A mutant of E7 (L67R) that does not bind Mi2/ HDAC (but still associates with pRb via its LxCxE motif) is defective in preventing arrest by either pRb (Brehm et al., 1999) or p16 (K Alevizopoulos and B Amati, unpublished). However, we failed to detect any interaction between HDAC-1 and E1A in Rat1 cells (data not shown). It is to be noted, furthermore, that HDAC-1 associates with pRb directly through an LxCxE motif (Brehm et al., 1998; . Thus, E1A would be expected to compete with HDAC for pRb binding, as was shown for E7 (Brehm et al., 1998) . Altogether, HDAC is unlikely to be the direct target of the GFP and SDDEDEE motifs of E1A. Alternative candidates include other ligands of the E7 Zinc ®nger, such as the S4 ATPase subunit of the 26S proteasome (Berezutskaya and Bagchi, 1997) or the homolog of the Drosophila tumor suppressor protein Tid56, hTid-1 (Schilling et al., 1998) . It is to be noted, however, that the exact implication of these interactions to the biological activities of E7 remains to be elucidated.
In the second scenario, the GFP and/or SDDEDEE motifs of E1A might be required to facilitate the removal of pRb from E2F, following interaction of the LxCxE motif with pRb. In fact, an analogous role was previously demonstrated for CR1 (Fattaey et al., 1993; Ikeda and Nevins, 1993) . Notably, E7 also binds pocket proteins via an LxCxE motif but, unlike E1A, does not dissociate them from E2F (Arroyo et al., 1993) , and both E7 and HDAC1 (but not all pRbbinding proteins) display an acidic stretch very similar to SDDEDEE (Figure 1b) . Thus, SDDEDEE is unlikely to contribute to the release of E2F. Dierent roles of GFP and SDDEDEE may also underlie the dierential eects of our mutants on cellular gene expression.
A dual action of E1A involving: (1) association with E2F-Rb complexes via the LxCxE motif, preventing binding of HDAC; and (2) release of free E2F through the action of CR1 (and possibly the GFP motif) would be analogous to the proposed roles of cyclin/CDK complexes in Rb inactivation (Harbour et al., 1999) .
These are (1) masking of the HDAC-interaction domain by cyclin D/CDK4, followed by (2) disruption of the pocket structure ± and hence release of free E2F ± by cyclin E/CDK2. As proposed by the same authors, these two regulatory events might dierentially aect expression of distinct E2F-target genes. It must be noted, however, that the GFP and SDDEDEE motifs of E1A are both required to oset inhibition of CDK4 and/or CDK6 by p16, pointing to a more complex role of these kinases. Understanding how the GFP and SDDEDEE motifs function in preventing cell cycle arrest is likely to shed new light on G1-S control in mammalian cells.
Materials and methods
Retroviral infections, cell cycle analysis, biochemical analysis and Northern (RNA) blot analysis
The retroviral vectors pBabe-Puro (pBP), -Neo2 (pBN2), and Hygro2 (pBH2) were described previously (Morgenstern and Land, 1990; Vlach et al., 1996) . cDNAs encoding mutants of Ade 5 12S E1A (GFP-A3, DDE-A6, LDL-A4 and DC52) were constructed by PCR with appropriate primers and subcloned in pBH2 or pBN2. All mutations were veri®ed by sequencing. Retroviruses encoding human p16 (pBP-p16), p27 (pBP-p27) and wild type 12S E1A (pBH2-E1A) were described previously (Alevizopoulos et al., 1997 (Alevizopoulos et al., , 1998 Vlach et al., 1996) . High-titer retroviral supernatants were generated as described (Vlach et al., 1996) . Infected Rat1 cells were selected with either G418 (Calbiochem, 1000 mg/ml), hygromycin (Calbiochem, 150 mg/ml), or puromycin (Sigma, 2.5 mg/ml). Serial infections of cell pools, preparation of cell lysates and biochemical analysis (immunoblots, immunoprecipitations) were as previously described (Vlach et al., 1996) . For cell cycle analysis, cells were labeled with 33 mM Bromodeoxyuridine (BrdU) for 30 min and analysed by immunocytochemical detection of BrdU, as previously described (Alevizopoulos et al., 1997) . Northern blot analysis were performed as previously described (Alevizopoulos et al., 1998) .
Transient transfections
Rat1 cells were transiently transfected with the Eectene Transfection Reagent according to the instructions of the manufacturer for 12-well plates (Qiagen). Transfection reactions contained 50 ng of an Adenoviral E2/E3 promoter-Fire¯y Luciferase (FL) construct (a gift from Richard Iggo) together with 250 ng of either empty CMV vector or CMV-driven E1A constructs (12S or mutants) and 5 ng of a CMV-driven Renilla-Luciferase (CMV-RL) construct (Promega) as an internal control. 293T cells were transiently transfected with a standard Calcium phosphate-DNA precipitation procedure in 12-well plates. Transfection mixes contained 0.5 mg of a cyclin E promoter-FL reporter , 0.5 mg of CMV-E2F-1 and CMV-DP-1 expression plasmids, 0.75 mg of CMV-pRb, 1.25 mg of CMV-E1A (12S E1A or mutants) and 1 ng of CMV-RL. Where CMV-pRb or CMV E1A were omitted, they were replaced by an equal amount of the empty CMV-promoter vector. All transfected cells were incubated in DMEM (Gibco ± BRL 31966-021) with 10% fetal-calf serum and harvested 24 ± 36 h post-transfection. Cells were lysed and Luciferase activities were measured following standard procedures (Dual Luciferase assay, Promega) using a Lumac Biocounter M2500. RL activity was used to normalize FL activity within each sample.
Antibodies
The following antibodies were used. Against E1A: M73 (Santa Cruz, sc-025) or M29 (a gift from Ed Harlow); p27: C19 (sc-528); CDK2: M2 (sc-163); cdc2: 17 (sc-54); pRb: 14001A (Pharmingen); p107: C18 (sc-318); p130: C20 (sc-317); p16: DCS 50.2 (a gift from G Peters); MCM4, MCM3 (a gift from Ken Raj).
